Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2022 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| AG-RISPERIDONE | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-SIMVASTATIN | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-SIMVASTATIN | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-RISPERIDONE | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-RISPERIDONE | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-ESCITALOPRAM | angita pharma inc. | Marketed | Sep 6, 2018 | Marketed |
| AG-SIMVASTATIN | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-IRBESARTAN HCTZ | angita pharma inc. | Cancelled Post Market | Sep 6, 2018 | Cancelled Po... |
| AG-RAMIPRIL | angita pharma inc. | Marketed | Sep 6, 2018 | Marketed |
| AG-IRBESARTAN HCTZ | angita pharma inc. | Cancelled Post Market | Sep 6, 2018 | Cancelled Po... |
| AG-RISPERIDONE | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-RAMIPRIL | angita pharma inc. | Marketed | Sep 6, 2018 | Marketed |
| AG-OLMESARTAN | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-SIMVASTATIN | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-SERTRALINE | angita pharma inc. | Marketed | Sep 6, 2018 | Marketed |
| AG-IRBESARTAN HCTZ | angita pharma inc. | Cancelled Post Market | Sep 6, 2018 | Cancelled Po... |
| AG-AMOXICILLIN | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-OLMESARTAN | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-RISPERIDONE | angita pharma inc. | Dormant | Sep 6, 2018 | Dormant |
| AG-ESCITALOPRAM | angita pharma inc. | Marketed | Sep 6, 2018 | Marketed |
